GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Market Cap

CNBX Pharmaceuticals (CNBX Pharmaceuticals) Market Cap : $0.28 Mil (As of May. 30, 2024)


View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CNBX Pharmaceuticals's share price for the quarter that ended in Feb. 2024 was $0.012. CNBX Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 31.11 Mil. Therefore, CNBX Pharmaceuticals's market cap for the quarter that ended in Feb. 2024 was $0.37 Mil.

CNBX Pharmaceuticals's quarterly market cap declined from Aug. 2023 ($0.38 Mil) to Nov. 2023 ($0.34 Mil) but then increased from Nov. 2023 ($0.34 Mil) to Feb. 2024 ($0.37 Mil).

CNBX Pharmaceuticals's annual market cap declined from Aug. 2021 ($25.27 Mil) to Aug. 2022 ($4.28 Mil) and declined from Aug. 2022 ($4.28 Mil) to Aug. 2023 ($0.38 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CNBX Pharmaceuticals's Enterprise Value for Today is $1.53 Mil.


CNBX Pharmaceuticals Market Cap Historical Data

The historical data trend for CNBX Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Market Cap Chart

CNBX Pharmaceuticals Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.08 25.80 25.27 4.28 0.38

CNBX Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.33 0.38 0.34 0.37

Competitive Comparison of CNBX Pharmaceuticals's Market Cap

For the Biotechnology subindustry, CNBX Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CNBX Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Market Cap falls into.



CNBX Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CNBX Pharmaceuticals's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as

Market Cap (A: Aug. 2023 )=Share Price (A: Aug. 2023 )*Shares Outstanding (EOP) (A: Aug. 2023 )
=$0.0169*22.6113
=$0.38

CNBX Pharmaceuticals's Market Cap for the quarter that ended in Feb. 2024 is calculated as

Market Cap (Q: Feb. 2024 )=Share Price (Q: Feb. 2024 )*Shares Outstanding (EOP) (Q: Feb. 2024 )
=$0.012*31.1113
=$0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CNBX Pharmaceuticals  (OTCPK:CNBX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


CNBX Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


CNBX Pharmaceuticals (CNBX Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. The company tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.
Executives
Cannabics Inc. 10 percent owner 108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills director, officer: President, CEO, CFO
North American Mining Corp 10 percent owner 6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford director, officer: Vice-President, Secretary